References
- Ponka P, Lok CN. The transferrin receptor: role in health and disease. Int J Biochem Cell Biol 1999;31:1111–1111.
- Daniels TR, Delgado T, Rodriguez JA, . The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006;121:144–144.
- Ciechanover A, Schwartz AL, Lodish HF. Sorting and recycling of cell surface receptors and endocytosed ligands: the asialoglycoprotein and transferrin receptors. J Cell Biochem 1983;23:107–107.
- Larrick JW, Enns C, Raubitschek A, . Receptor-mediated endocytosis of human transferrin and its cell surface receptor. J Cell Physiol 1985;124:283–283.
- Das Gupta A, Shah VI. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Hematol Pathol 1990;4:37–37.
- White S, Taetle R, Seligman PA, . Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects. Cancer Res 1990;50:6295–6295.
- Kasibhatla S, Jessen KA, Maliartchouk S, . A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid. Proc Natl Acad Sci USA 2005;102:12095–12095.
- Horonchik L, Wessling-Resnick M. The small-molecule iron transport inhibitor ferristatin/NSC306711 promotes degradation of the transferrin receptor. Chem Biol 2008;15:647–647.
- Ng PP, Dela Cruz JS, Sorour DN, . An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proc Natl Acad Sci USA 2002;99:10706–10706.
- Callens C, Moura IC, Lepelletier Y, . Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody. Leukemia 2008;22:42–42.
- Daniels TR, Delgado T, Helguera G, . The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol 2006;121:159–159.
- Crepin R, Goenaga AL, Jullienne B, . Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas. Cancer Res 2010;70:5497–5497.
- Peer D, Karp JM, Hong S, . Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751–751.
- Ng PP, Helguera G, Daniels TR, . Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood 2006;108:2745–2745.
- Laubach JP, Richardson PG, Anderson KC. The evolution and impact of therapy in multiple myeloma. Med Oncol 2010;27(Suppl. 1):S1–S6.
- Daniels TR, Ng PP, Delgado T, . Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Mol Cancer Ther 2007;6:2995–2995.
- Rodriguez JA, Helguera G, Daniels TR, . Binding specificity and internalization properties of an antibody-avidin fusion protein targeting the human transferrin receptor. J Control Release 2007;124:35–35.
- Ortiz-Sanchez E, Daniels TR, Helguera G, . Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia 2009;23:59–59.
- Xia F, Wang X, Wang YH, . Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res 1995;55:12–12.
- Lu TP, Lai LC, Lin BI, . Distinct signaling pathways after higher or lower doses of radiation in three closely related human lymphoblast cell lines. Int J Radiat Oncol Biol Phys 2010;76:212–212.
- Simunek T, Boer C, Bouwman RA, . SIH—a novel lipophilic iron chelator—protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death. J Mol Cell Cardiol 2005;39:345–345.
- Beltran-Parrazal L, Lopez-Valdes HE, Brennan KC, . Mitochondrial transport in processes of cortical neurons is independent of intracellular calcium. Am J Physiol Cell Physiol 2006;291:C1193–1197.
- Kirchhausen T, Macia E, Pelish HE. Use of dynasore, the small molecule inhibitor of dynamin, in the regulation of endocytosis. Methods Enzymol 2008;438:77–77.
- Feo-Zuppardi FJ, Taylor CW, Iwato K, . Long-term engraftment of fresh human myeloma cells in SCID mice. Blood 1992;80:2843–2843.
- Markman M. Intraperitoneal antineoplastic drug delivery: rationale and results. Lancet Oncol 2003;4:277–277.
- Breuer W, Epsztejn S, Cabantchik ZI. Dynamics of the cytosolic chelatable iron pool of K562 cells. FEBS Lett 1996;382:304–304.
- Lin SM, Du P, Huber W, . Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res 2008;36:e11.
- Daniels TR, Neacato II, Rodriguez JA, . Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cells. Leukemia 2010;24:1555–1555.
- Saletta F, Rahmanto YS, Noulsri E, . Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53. Mol Pharmacol 2010;77:443–443.
- Richardson DR, Kalinowski DS, Lau S, . Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents. Biochim Biophys Acta 2009;1790:702–702.
- Gao J, Richardson DR. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: the mechanisms involved in inhibiting cell-cycle progression. Blood 2001;98:842–842.
- Suzuki E, Daniels TR, Helguera G, . Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis. Int J Oncol 2010;36:1299–1299.
- Taetle R, Castagnola J, Mendelsohn J. Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. Cancer Res 1986;46:1759–1759.
- Moura IC, Lepelletier Y, Arnulf B, . A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients. Blood 2004;103:1838–1838.
- Tacchini L, Bianchi L, Bernelli-Zazzera A, . Transferrin receptor induction by hypoxia. HIF-1-mediated transcriptional activation and cell-specific post-transcriptional regulation. J Biol Chem 1999;274:24142–24142.
- Piccinelli P, Samuelsson T. Evolution of the iron-responsive element. RNA 2007;13:952–952.
- Templeton DM, Liu Y. Genetic regulation of cell function in response to iron overload or chelation. Biochim Biophys Acta 2003;1619:113–113.